文献速递甲状腺疾病

临床医生对甲状腺微小乳头状癌管理与术语的看法:一项定性研究

Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.
PubMed 文献 · Thyroid · 2017-03-21

该定性研究于2015年11月至2016年5月对22名临床医生(7名内分泌科医生、15名甲状腺外科医生)进行半结构化访谈,分析其对甲状腺微小乳头状癌诊断、术语变更及治疗选择的看法。结果显示,医生普遍知晓过度诊断与过度治疗,但几乎不接受主动监测,多数不认为更改术语可行,多数认为<1 cm甲状腺结节不应活检。作者指出样本不具代表性是重要局限。

要点

  • 医生普遍知晓甲状腺微小乳头状癌的过度诊断与过度治疗,但几乎不接受主动监测。
  • 多数医生不认为更改该诊断术语能减少患者焦虑及对积极治疗的偏好。
  • 多数医生认为<1 cm的甲状腺结节不应活检,以减少过度诊断风险。

核心结论

  • 作者认为,在证据更强之前,临床医生可能尚未准备好接受非手术选项或术语变更;该研究基于22名医生的非代表性样本,这仍是重要局限。

研究设计与样本

  • 定性研究,采用半结构化访谈,访谈时间为2015年11月至2016年5月,共纳入22名临床医生(7名内分泌科医生和15名甲状腺外科医生)。
  • 对访谈录音转录后行主题编码,并采用框架法分析数据。

主要发现

  • 在管理甲状腺癌患者的医生样本中,对甲状腺微小乳头状癌过度诊断与过度治疗的知晓较为普遍。
  • 医生对主动监测的接受度很低,因担心转移风险、认为支持该方法的证据不够强、并认为患者目前对手术的偏好较高,而不愿推荐该方法。
  • 多数医生不认为更改该诊断术语是减少患者焦虑及其对更积极治疗偏好的可行策略。
  • 多数医生认为<1 cm的甲状腺结节不应活检,这可能有助于减少甲状腺微小乳头状癌过度诊断的风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 该研究基于22名临床医生的非代表性样本,这仍是重要局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is growing acceptance that the increase in thyroid cancer incidence is in part a result of overdiagnosis of small low-risk papillary microcarcinomas (PMCs) with indolent clinical course. Although surgery is the cornerstone treatment for patients with PMCs, recent management guidelines are shifting toward inclusion of more conservative treatments such as active surveillance. There is little evidence on clinicians' experience in managing PMC patients and their attitudes toward treatment options, including their willingness to accept a nonsurgical option. The aim of this study was to understand how clinicians perceive a diagnosis of PMC, potential changes to terminology, and the treatment options available to patients. METHODS: This was a qualitative study using semi-structured interviews conducted between November 2015 and May 2016 with 22 clinicians (seven endocrinologists and 15 thyroid surgeons). Transcribed audio-recordings were thematically coded, and a framework method was used to analyze the data. RESULTS: Across a sample of clinicians who manage thyroid cancer patients, awareness of overdiagnosis and overtreatment of PMC was common. However, there was little acceptance of active surveillance to manage these patients. Clinicians did not feel comfortable recommending this management approach, as they were worried about the risk of metastases, did not feel that evidence to support this approach was strong enough, and also believed that patients currently have a high preference for surgery. The majority of clinicians did not believe that changing the terminology of this diagnosis was a viable strategy to reduce patients' anxiety and their perceived preference for more aggressive treatments. However, most clinicians felt that thyroid nodules <1 cm should not be biopsied, which could help minimize the risk of overdiagnosis of PMC. CONCLUSIONS: This study, based on a non-representative sample of 22 clinicians, which remains an important limitation, provides revealing insight into clinicians' management preferences and decision making for small low-risk thyroid cancers at a time when management guidelines and practices are evolving. It suggests that clinicians may not be ready to accept nonsurgical options, or changes in terminology, until evidence to support these options and changes is stronger.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Nickel B, Brito JP, Barratt A, et al. Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study. Thyroid. 2017. PMID: 28322617. doi:10.1089/thy.2016.0483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。